Research protocols typically begin at 0.25mg daily for 35 days to assess tolerance before increasing to 0.51.0mg maintenance dose
Examples include insulin, such as insulin lispro (Humalog), and sulfonylureas, such as glimepiride (Amaryl)
Semaglutide is a large peptide molecule that the body naturally breaks down before it can be absorbed through oral tissues
Many people notice reduced appetite within the first few weeks, though meaningful weight loss builds gradually over months as the dose is titrated upward
This is particularly important for patients also taking insulin or sulfonylureas, as the risk of hypoglycaemia is already increased with these combinations
Retrieved 14 May 2022, from A Phase III, Multicentre, Double-Blind, Randomised, Placebo-Controlled Study to Confirm the Safety and Efficacy of Subcutaneous Bioresorbable Afamelanotide Implants in Patients with Erythropoietic Protoporphyria (EPP)